Recall record at a glance
| Official record | F-2759-2015 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | Lavoi Corporation d/b/a/ Epi De France |
| Report date | Jul 1, 2015 |
| Recall initiation date | Feb 24, 2015 |
| Location | Atlanta, GA, United States |
Official product description
Zaxbys, Nibbler Bun, 180 count case, Lavoi Corporation, EPI Breads, 4710 West Ledbetter, Dallas, TX 75236.
Why the product was recalled
Undeclared allergen: Bread products were manufactured using raw material (wheat gluten) that was recalled due to undeclared peanut and/or tree nut residue.
Distribution information
AL, AR, AZ, CA, CO, FL, GA, IL, IN, KS, LA, MN, MO, MS, NC, NE, NY, PA, OH, OK, OR, SC, TX, VA, TN UT, and WA.
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.